Mothers planning their postpartum GLP-1 strategy should factor in this ramp-up period
Jerath, our Harvard trained Chief Medical Doctor, we first take time to listen, learn your story, and understand what your body truly needs
329,330 In degenerative joint diseases like OA, the metabolic balance of chondrocytes is disrupted, leading to the overproduction of degrading enzymes and inflammatory mediators, including iNOS, MMP-13, and ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5), which participate in cartilage degradation and inflammatory processes
This allows for once a week dosing, like other newer GLP-1s
This information, interpreted with your provider, can support a more evidence-informed discussion about whether GLP-1 therapy fits your unique clinical picture
Novo Nordisk cited concerns about Hims & Hers selling and promoting knockoff compounded GLP-1 drugs, which are more affordable versions of the popular weight loss medications
